September 30, 2011

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan

Sponsor and Collaborators
Bayer

Contact
Bayer Clinical Trials
clinical-trials-contact@bayerhealthcare.com

Study Director
Bayer Study Director

ClinicalTrials.gov Identifier
NCT01419327
Similar Articles

More in Hyperphosphatemia Clinical Trials

Dose-finding Study of MCI-196

A look at the following clinical trial: Dose-finding Study of MCI-196.

A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With ...

A look at the following clinical trial: A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis.

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

A look at the following clinical trial: Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis.